RNA Therapeutics: Bridging Discovery and Clinical Implementation.

Area of Science:

• Biotechnology
• Molecular Biology
• Pharmacology

Background:

• RNA-based therapeutics leverage RNA molecules for diverse therapeutic interventions.
• Key technologies include ribozymes, RNA interference, CRISPR interference, and messenger RNA (mRNA).
• Progress is driven by chemical modifications and advanced delivery systems like lipid nanoparticles.

Purpose of the Study:

• To provide a comprehensive summary of current RNA technologies.
• To detail their targeting mechanisms and clinical progress.
• To outline challenges in delivery, efficacy, and safety.

Main Methods:

• Review of current RNA-based therapeutic approaches.
• Analysis of targeting mechanisms.
• Evaluation of clinical advancements and delivery strategies.

Main Results:

• RNA therapeutics can target virtually any cellular genetic component.
• They offer potential for treating diseases previously intractable with small molecules.
• Significant progress has been made in chemical modifications and delivery systems.

Conclusions:

• RNA-based therapeutics represent a powerful and versatile class of drugs.
• Continued innovation in delivery and safety is crucial for broader clinical adoption.
• These technologies hold promise for addressing a wide range of unmet medical needs.